Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older
Clinical trial NCT01114620 · COMPLETED
Trial details
- NCT number
- NCT01114620
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-17
- Primary completion
- 2010-11-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.